Alle Storys
Folgen
Keine Story von Dr. Hönle AG mehr verpassen.

Dr. Hönle AG

euro adhoc: Dr. Hönle AG
Quarterly or Semiannual Financial Statements
Hönle continues on a strong course of growth (E)

Disclosure announcement transmitted by euro adhoc. The issuer is
responsible for the content of this announcement.
Gräfelfing/Munich, 14  August, 2003
Hönle (ISIN: DE 0005157101), a leading provider of industrial UV
technology systems, has succeeded in continuing its course of growth
as from the beginning of the financial year.  Quarterly sales
increased by 30 percent in comparison to the previous year’s quarter.
Overall, sales for the first three quarters were TEUR 11,744 or 21
percent up on the previous year’s quarter.
The Group’s income figures were also further expanded both in
comparison to the second quarter of the current financial year as
well as in comparison to the previous year’s period. EBIT rose from
TEUR -866 in the previous year to TEUR 537 in the first nine months
of the current financial year. In view of the still restrained demand
for capital goods, the Group considers its present business
development with a 5 percent EBIT margin to be positive. In
comparison to the same period in the previous year, EBT and net
income saw a rise from TEUR  -392 and TEUR -249 respectively to TEUR
995 and TEUR 1,049. Relative to 5.24 million shares, earnings per
share climbed from EUR -0.05 in the previous year to EUR 0.20 this
year.
The Hönle Group is still very solidly financed: the capital ratio is
86 percent. Liquid funds amount to TEUR 14,864 as at 30 June 2003,
and financial assets are TEUR 579; this corresponds to an equivalent
value of EUR 2.95 per share.
Outlook
The third quarter was characterized by a strong increase in incoming
orders. At the end of June 2003, the Dr. Hönle AG order volume was
the highest ever in the 27 years of the firm’s history. We therefore
expect that the fourth quarter will perform best in this financial
year and that the results at year-end will probably be significantly
up on those of the end of the third quarter. Among other things, the
newly acquired key accounts are expected to make a positive
contribution to sales and income development in the coming financial
year.
end of announcement        euro adhoc 14.08.2003

Further inquiry note:

Peter Weinert
Tel.: +49 (0)89 856 08 173
E-Mail: peter.weinert@hoenle.de
www.hoenle.de

Branche: Instrument Engineering
ISIN: DE0005157101
WKN: 515710
Index: CDAX, Prime All Share, Prime Standard, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Niedersächsische Börse zu Hannover / free trade
Berliner Wertpapierbörse / free trade
Bayerische Börse / free trade
Hamburger Wertpapierbörse / free trade
Bremer Wertpapierbörse (BWB) / free trade
Börse Düsseldorf / free trade
Baden-Württembergische Wertpapierbörse / free trade

Weitere Storys: Dr. Hönle AG
Weitere Storys: Dr. Hönle AG